tirzepatide ruling january 2025 Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Zepbound No Longer in Shortage:

[] Glucagon-like peptide-1 and idiopathic intracranial hypertension IIH involves an elevation in intracranial pressure (ICP), often leading to papilledema and optic nerve compression, which can pose a risk of irreversible visual impairment

Biochemistry 60 , 966990 (2021)

What the study does provide is a clinical signal that aligns with the mechanistic story

Zepbound is the brand name for tirzepatide, a once-weekly injectable medication

Removal from Category 2 does not automatically grant Category 1 status

A single monthly injection from the manufacturer can range from $900 to $1,500 depending on your dosage level and pharmacy, even with some insurance coverage